Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

Matching articles

Showing 73–84 of 134 articles · Explore study findings

Clear search and filters

  • Explore study findings

    What mouse experiments found about kisspeptin-10 and blood glucose

    Kisspeptin-10, or KP-10, is the ten-amino-acid signaling segment shared by longer kisspeptins and can activate the receptor KISS1R. Most human research on KP-10 measures reproductive hormones.

    Kisspeptin-102 sources (2025, 2026)

  • Explore study findings

    Why timing mattered in a human kisspeptin-10 study

    Kisspeptin-10, also called KP-10, is a ten-amino-acid fragment of the human kisspeptin precursor. It can stimulate the brain's gonadotropin-releasing hormone pathway. An August 2026 study asked whether intermittent exposure would sustain measurable pituitary hormone responses in healthy men.

    Kisspeptin-102 sources (2024, 2026)

  • Explore study findings

    What frequent blood samples showed during continuous kisspeptin-10 exposure

    Kisspeptin-10, or KP-10, is the ten-amino-acid fragment also called kisspeptin 112–121. It activates the kisspeptin receptor upstream of gonadotropin-releasing hormone. A 2026 experiment in healthy men tracked what happened to luteinizing hormone (LH) during continuous KP-10 exposure.

    Kisspeptin-101 source (2026)

  • Explore study findings

    Could kisspeptin-10 provoke a vasopressin response?

    Kisspeptin-10, or KP-10, is a ten-amino-acid peptide best studied for signaling through the kisspeptin receptor in reproductive physiology. A study published online in November 2025 tested a different question.

    Kisspeptin-101 source (2025)

  • Explore study findings

    What a 2026 colitis study found for a modified form of KPV

    KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. A 2026 study examined a chemically modified form that the authors called proKPV. It asked whether the modified material behaved differently from the unmodified peptide in animal models.

    KPV1 source (2026)

  • Explore study findings

    What HHS's October 2026 notice says about KPV

    KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. An October 2026 U.S. Department of Health and Human Services policy identifies a specific acetate form of KPV in an interim policy concerning compounding.

    KPV3 sources (2026)

  • Explore study findings

    Why Lipopeptide Names a Class Rather Than One Substance

    A lipopeptide has both a peptide component and a lipid component. Lipids interact differently with water than many peptide chains do, so joining the two can influence where the material goes or how it assembles.

    Lipopeptide2 sources (2026)

  • Explore study findings

    Why Some Lipopeptides Form Tapes and Others Form Micelles

    A 2026 study compared how two defined lipopeptides formed such structures. Lucas de Mello and colleagues examined a palmitoyl pentapeptide used in cosmetic research and a related compound with changes in its charged amino acids. They compared the two in different salt forms and environments.

    Lipopeptide1 source (2026)

  • Explore study findings

    What a Skin Immunity Study Reveals About Bacterial Lipopeptides

    A chain with an attached lipid is one kind of lipopeptide, and microbes as well as laboratories can produce materials in this broad class. A 2026 study of bacterial lipopeptides asked how certain soluble materials affected a signal released by skin cells.

    Lipopeptide1 source (2026)

  • Explore study findings

    What exercise and liraglutide changed in a weight-maintenance study

    Liraglutide is a modified GLP-1 receptor agonist peptide. A 2026 analysis of the S-LiTE trial examined whether exercise, liraglutide or both changed measurements of blood vessel health after participants had already lost weight through a supervised program.

    Liraglutide1 source (2026)

  • Explore study findings

    Why a five-week body composition study reported amounts and percentages

    Liraglutide is a modified GLP-1 receptor agonist. A 2026 report from a small randomized study looked at how body composition changed during a short period, with special attention to the difference between the amount of lean tissue and its share of total body weight.

    Liraglutide1 source (2026)

  • Explore study findings

    What a negative cell study contributed to the MGF debate

    The short material commonly called the MGF peptide is a laboratory peptide based on part of an insulin-like growth factor 1 precursor. An older experiment published online in 2013 examined whether it would change the activity of muscle precursor cells.

    MGF1 source (2013)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)